Geschatte realtime
Cboe BZX
19:46:06 27-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,235
USD
|
+4,08%
|
|
+1,16%
|
+122,46%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
58,4
|
63,7
|
120
|
123,3
|
38,66
|
82,46
|
-
|
Bedrijfswaarde
1 |
58,4
|
63,7
|
120
|
123,3
|
38,66
|
82,46
|
82,46
|
K/w-verhouding
|
-35,4
x
|
-9,19
x
|
28,9
x
|
5,08
x
|
78,7
x
|
17,3
x
|
10,6
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,14
x
|
6,65
x
|
4,44
x
|
2,77
x
|
1,58
x
|
2,41
x
|
2,01
x
|
Bedrijfswaarde/omzet
|
2,14
x
|
6,65
x
|
4,44
x
|
2,77
x
|
1,58
x
|
2,41
x
|
2,01
x
|
Bedrijfswaarde/EBITDA
|
-72.849.106
x
|
-11.021.117
x
|
23.300.975
x
|
4.384.357
x
|
147.005.601
x
|
-
|
-
|
Bedrijfswaarde/FCF
|
-23.292.340
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
16.497
|
16.502
|
16.617
|
16.612
|
16.382
|
16.393
|
-
|
Referentieprijs
2 |
3,540
|
3,860
|
7,220
|
7,420
|
2,360
|
5,030
|
5,030
|
Datum van publicatie
|
13/02/20
|
25/02/21
|
10/02/22
|
9/02/23
|
8/02/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
27,26
|
9,577
|
27,04
|
44,53
|
24,4
|
34,28
|
41,1
|
EBITDA
|
-0,8016
|
-5,78
|
5,149
|
28,11
|
0,263
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-1,968
|
-8,234
|
4,12
|
14,83
|
-0,382
|
5,656
|
9,948
|
Operationele Marge
|
-7,22%
|
-85,98%
|
15,24%
|
33,3%
|
-1,57%
|
16,5%
|
24,21%
|
Resultaat voor belastingen (EBT)
1 |
-1,7
|
-6,836
|
4,119
|
27,99
|
0,652
|
6,47
|
10,35
|
Nettowinst (verlies)
1 |
-1,7
|
-6,836
|
4,119
|
24,24
|
0,485
|
4,801
|
7,866
|
Nettomarge
|
-6,24%
|
-71,37%
|
15,23%
|
54,44%
|
1,99%
|
14,01%
|
19,14%
|
WPA
2 |
-0,1000
|
-0,4200
|
0,2500
|
1,460
|
0,0300
|
0,2900
|
0,4750
|
Free Cash Flow
|
-2,507
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-9,2%
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/02/20
|
25/02/21
|
10/02/22
|
9/02/23
|
8/02/24
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
13,02
|
10,34
|
12,08
|
9,01
|
13,1
|
3,414
|
4,527
|
3,898
|
12,57
|
10,66
|
6,87
|
5,19
|
11,56
|
11,5
|
8,4
|
EBITDA
|
5,55
|
16,86
|
4,684
|
2,276
|
4,294
|
-2,724
|
-0,976
|
-1,726
|
5,689
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
5,319
|
3,93
|
4,57
|
2,161
|
4,173
|
-2,939
|
-1,127
|
-1,895
|
5,577
|
2,887
|
0,322
|
-0,686
|
3,133
|
-
|
-
|
Operationele Marge
|
40,84%
|
38,02%
|
37,83%
|
23,98%
|
31,84%
|
-86,09%
|
-24,9%
|
-48,61%
|
44,38%
|
27,07%
|
4,69%
|
-13,22%
|
27,11%
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
5,318
|
16,71
|
4,594
|
2,279
|
4,408
|
-2,696
|
-0,882
|
-1,576
|
5,805
|
3,101
|
0,522
|
-0,486
|
3,333
|
-
|
-
|
Nettowinst (verlies)
1 |
5,318
|
16,06
|
3,524
|
1,829
|
2,831
|
-1,894
|
-0,38
|
-1,451
|
4,21
|
2,274
|
0,392
|
-0,365
|
2,5
|
-
|
-
|
Nettomarge
|
40,83%
|
155,37%
|
29,17%
|
20,3%
|
21,6%
|
-55,48%
|
-8,39%
|
-37,22%
|
33,5%
|
21,33%
|
5,71%
|
-7,03%
|
21,64%
|
-
|
-
|
WPA
2 |
0,3200
|
0,9700
|
0,2100
|
0,1100
|
0,1700
|
-0,1200
|
-0,0200
|
-0,0900
|
0,2600
|
0,1400
|
0,0200
|
-0,0250
|
0,1550
|
0,1600
|
0,0700
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/02/22
|
5/05/22
|
4/08/22
|
3/11/22
|
9/02/23
|
3/05/23
|
3/08/23
|
9/11/23
|
8/02/24
|
10/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-2,51
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/02/20
|
25/02/21
|
10/02/22
|
9/02/23
|
8/02/24
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
5,03
USD Gemiddelde koersdoel
10
USD Spread / Gemiddelde doel +98,81% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +122,46% | 82,46 mln. | | -34,99% | 14,88 mld. | | -54,41% | 2,26 mld. | | +16,54% | 1,89 mld. | | -11,85% | 1,52 mld. | | +19,90% | 1,19 mld. | | -29,99% | 871 mln. | | +2,21% | 781 mln. | | -35,68% | 750 mln. | | -29,12% | 591 mln. |
Medisch diagnose- & testmateriaal
|